Sign In  |  Register  |  About Menlo Park  |  Contact Us

Menlo Park, CA
September 01, 2020 1:28pm
7-Day Forecast | Traffic

  • Search Hotels in Menlo Park

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

BeyondSpring, Inc. - Ordinary Shares (NQ: BYSI )

1.690 UNCHANGED
Streaming Delayed Price Updated: 1:00 PM EST, Dec 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about BeyondSpring, Inc. - Ordinary Shares

< Previous 1 2 3 4 5 6 Next >
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Vivos Therapeutics (NASDAQ:VVOS) stock rose 45.44% to $5.58 during Monday's regular session. As of 12:30 EST, Vivos Therapeutics's stock is trading at a... 
Via Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares climbed 187.8% to $17.53 after the company agreed to be acquired by Pfizer for $18.50 per share, implying an equity value... 
Via Benzinga
This Biotech Stock Just Skyrocketed by 170%. Is It a Buy?
Don't be too quick to pull the trigger. 
Via The Motley Fool
The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight
Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,... 
Via Benzinga
Exposures Product Safety
Unusual Options Activity Insight: BeyondSpring
Shares of BeyondSpring (NASDAQ:BYSI) saw some unusual opti... 
Via Benzinga
The Daily Biotech Pulse: Merck Reports Positive Keytruda Readout, Moderna Slips Despite Q2 Beat, Bayer To Buy Vividion For Up To $2B, GlycoMimetics Gets New CEO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 4) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
84 Biggest Movers From Friday
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares surged 41.3% to close at $4.86 on Friday after the company inked an agreement with turnkey mining solutions provider Hertford... 
Via Benzinga
Week In Review: China Life Science Posts $1.3 Billion In Deals
Pacific Biosciences, a San Francisco Bay area company offering long-read sequencing platforms, will acquire Omniome for up to $800 million. Zai Lab and Schrödinger formed a collaboration to develop a... 
Via Talk Markets
Why BeyondSpring's Stock Is Soaring Higher
BeyondSpring Inc (NASDAQ: BYSI) shares are trading higher by 22.5% at $26.59 Friday afternoon on continued strength after the company earlier in the week announced results from... 
Via Benzinga
Employment Data Boosts Dow, S&P 500 to Fresh Highs
The Dow Jones Industrial Average is up 120 points at midday, after earlier scoring a fresh intraday high alongside the S&P 500 Index, on the heels of an upbeat jobs report. 
Via Talk Markets
Topics Stocks
Exposures US Equities
12 Health Care Stocks Moving In Friday's Intraday Session
Gainers SCWorx (NASDAQ:WORX) shares moved upwards by 20.59% to $3.08 during Friday's regular session. The current volume of 16.2 million shares is 348.19% of SCWorx... 
Via Benzinga
Mid-Morning Market Update: Markets Mostly Higher; US Economy Adds 943,000 Jobs
Following the market opening Friday, the Dow traded up 0.37% to 35,193.61 while the NASDAQ fell 0.26% to 14,857.09. The S&P also rose, gaining 0.16% to 4,436.02. The U.S. has... 
Via Benzinga
Topics Economy Stocks
Exposures Economy US Equities
55 Stocks Moving In Friday's Mid-Day Session
Gainers Sphere 3D Corp. (NASDAQ: ANY) shares jumped 29.9% to $4.47 after the company inked an agreement with turnkey mining solutions provider Hertford Advisors Ltd to provide a... 
Via Benzinga
EXCLUSIVE: BeyondSpring CEO Talks Better-Than-Expected Trial Results That Sent The Stock Soaring
BeyondSpring Inc (NASDAQ: BYSI) recently announced positive topline data from its DUBLIN-3 registrational trial in plinabulin in combination with docetaxel for the... 
Via Benzinga
26 Stocks Moving in Thursday's Pre-Market Session
Gainers Ensysce Biosciences, Inc. (NASDAQ: ENSC) shares rose 34% to $5.48 in pre-market trading after dropping around 15% on Wednesday. Ensysce Biosciences recently appointed... 
Via Benzinga
99 Biggest Movers From Yesterday
Gainers Score Media and Gaming Inc. (NASDAQ: SCR) shares climbed 79.9% to close at $32.64 on Thursday after the company, and Penn National Gaming, announced they entered into a... 
Via Benzinga
88 Biggest Movers From Yesterday
Gainers BeyondSpring Inc. (NASDAQ: BYSI) shares climbed 176% to close at $26.58 on Wednesday in reaction to topline data from DUBLIN-3 Phase 3 trial evaluating plinabulin in... 
Via Benzinga
Why BeyondSpring Stock Skyrocketed Today
The biotech's experimental cancer therapy could be a game-changer. 
Via The Motley Fool
Mid-Afternoon Market Update: Dow Falls 275 Points; BeyondSpring Shares Spike Higher
Toward the end of trading Wednesday, the Dow traded down 0.78% to 34,841.21 while the NASDAQ rose 0.29% to 14,803.80. The S&P also fell, dropping 0.26% to 4,411.84. The U.S.... 
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Down Triple Digits as Slew of Disappointing Earnings Roll In
A bevy of disappointing economic data and earnings reports are weighing on stocks this afternoon. 
Via Talk Markets
Topics Stocks
Exposures US Equities
These 2 Soaring Biotech Stocks Are Making the Nasdaq Stronger
The Nasdaq Composite is holding up better than its fellow market benchmarks. 
Via The Motley Fool
Topics Stocks
Exposures US Equities
BYSI Stock: The Huge Cancer News Sending BeyondSpring Skyrocketing Today
Shares of BYSI stock are soaring on Wednesday after pharmaceutical firm BeyondSpring released positive data regarding its lung cancer drug. 
Via InvestorPlace
Why BeyondSpring's Stock Is Rallying Today
BeyondSpring Inc. (NASDAQ: BYSI) shares are trading higher after the company announced results from its DUBLIN-3 trial of plinabulin in combination with docetaxel for non-small... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2021
Upgrades For Meritage Homes Corp (NYSE: 
Via Benzinga
Mid-Morning Market Update: Markets Mostly Lower; General Motors Tops Q2 Views
Following the market opening Wednesday, the Dow traded down 0.44% to 34,962.94 while the NASDAQ rose 0.03% to 14,765.20. The S&P also fell, dropping 0.23% to 4,412.83. The U.S... 
Via Benzinga
Topics Stocks
Exposures US Equities
BeyondSpring Stock Rockets 250% As Cancer Drug Tops Chemotherapy
BeyondSpring said Wednesday a regimen containing its cancer drug outperformed chemo in lung cancer patients, and BYSI stock catapulted. 
Via Investor's Business Daily
BeyondSpring Stock Is Up More than 300%: What You Need To Know?
BeyondSpring Inc (NASDAQ: BYSI) is trading over 300% up during premarket in reaction to topline data from DUBLIN-3 Phase 3 trial evaluating plinabulin in combination with... 
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers BeyondSpring (NASDAQ:BYSI) stock increased by 337.79% to $42.16 during Wednesday's pre-market session. The market value of their outstanding shares is at $1.6... 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Odonate Therapeutics (NASDAQ:ODT)... 
Via Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MenloPark.com & California Media Partners, LLC. All rights reserved.